ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Integrated Bioinformatic and Experimental Identification of DHCR24 and NRG1 as Key Cellular Aging Genes in Diabetic Cardiomyopathy.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Cell aging (CA) is increasingly recognized as a determinant in the pathogenesis of diabetic cardiomyopathy (DCM), yet the molecular mechanisms underlying this process remain unclear. This study aimed to identify aging-associated targets in diabetic cardiac cells and analyze alterations in intercellular ligand-receptor communication. Methods: Integrative bioinformatic analysis and single-cell transcriptomics were employed. Differentially expressed genes (DEGs) were extracted from a DCM-related dataset and intersected with 543 aging-associated genes, yielding five candidate genes (NRG1, IGFBP5, IL6, DHCR24, and CDKN1A). These candidates were further screened through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Subsequent validation involved TF-mRNA-miRNA network construction. The expression and functional roles of the final key genes were investigated using both in vivo (DCM mouse model) and in vitro (myocardial microvascular endothelial cells) models. Results: Exploratory single-cell transcriptomic profiling suggested NRG1 upregulation in monocytes from the DCM sample, while DHCR24 showed a trend of enrichment in endothelial cells in the single DCM sample analyzed. These preliminary observations, derived from a limited sample without biological replicates, serve to generate hypotheses regarding cell type-specific expression patterns that warrant validation in independent cohorts. In monocytes from DCM samples, while DHCR24 was primarily enriched in endothelial cells of the DCM group. In DCM mouse hearts, qRT-PCR and Western blot analyses confirmed that DHCR24 mRNA and protein levels were significantly downregulated (by approximately 2.89-fold and 1.82-fold, respectively), whereas NRG1 showed an upward trend. In vitro, silencing DHCR24 with siRNA in myocardial microvascular endothelial cells under high-glucose/high-lipid stress significantly reduced cell viability (eg, by 50% in CCK-8 assay) and exacerbated cellular aging phenotypes, including increased senescence-associated β-galactosidase (SA-β-Gal) activity and elevated expression of p21/p16, confirming its protective functional role in DCM pathogenesis. Conclusion: DHCR24 contributes to the fundamental molecular mechanisms driving DCM and represents a potential therapeutic target for diabetes-related cardiac microvascular injury. These findings, derived from a comprehensive approach spanning bioinformatics to in vivo and in vitro validation, provide robust experimental evidence advancing the understanding of DCM pathogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.